Literature DB >> 28148932

Neurodegenerative disease: Pituitary adenylate cyclase activator ameliorates SBMA.

Sarah Crunkhorn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28148932     DOI: 10.1038/nrd.2017.11

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy.

Authors:  Maria Josè Polanco; Sara Parodi; Diana Piol; Conor Stack; Mathilde Chivet; Andrea Contestabile; Helen C Miranda; Patricia M-J Lievens; Stefano Espinoza; Tobias Jochum; Anna Rocchi; Christopher Grunseich; Raul R Gainetdinov; Andrew C B Cato; Andrew P Lieberman; Albert R La Spada; Fabio Sambataro; Kenneth H Fischbeck; Illana Gozes; Maria Pennuto
Journal:  Sci Transl Med       Date:  2016-12-21       Impact factor: 17.956

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.